I don’t understand the market?! How does $TRIL announcing the dosing of First Patient in Phase 1b/2 Study of TTI-622 in Combination With Azacitidine and Venetoclax in TP53-Wild Type Acute Myeloid Leukemia get a negative response from market? Heading down…$9.55??

Wtf? Can someone explain this precipitous drop in $TRIL? It makes no sense? They announce positive single agent activity, combo activity, activity in both sold and liquid tumors, add a veteran M&A expert to the board and announce FPI for ph1b/2 and still the market shits on it?!

Maybe I should have kept posting as I think $PFE got $TRIL a bit too cheap (but like it wouldn't have made a big difference on stock price). I have however earned well on these shares and I expect (and hope) these $TRIL #CD47 drugs will benefit many cancer patients in the future.

npr.org/2021/10/28/104…

Why is talking about Trump? #letitgo and address the issues in this country. #notaleader

BDS Black with a big W to start the TFN's Run 4 Roses tournament! Leading the way was liv murray with 17 and Gianna Donato with 16!

Intensity 📈 on Day Two of #Roses22. 🌹🏀 #Run4Roses #HerTimeToPlay

We up NEXT! TFN's Run 4 Roses Bash Hudson

Run for the Roses champions! 6-0 sweep!!#BDS #RunfortheRoses

Approximately 4% of people with #NSCLC have a #BRAF mutation. 1/2

We’re honored to be supporting STAAR OC Foundation’s Step Up America for Ovarian Cancer to help bring awareness to #lowgradeserous #ovariancancer. #ColorItTeal

Coastal Carolina's hockey team is 3-1 to start the season, which may be surprising for some since they have to drive nearly two hours away just to get on some ice. It's the dedication and brotherhood which has led this team to back-to-back ACCHL titles. @CCU_Hockey

The Rams kick off 2023 on the road this afternoon at Milton Academy. Puck drop is set for 2:00.

Rams win it 6-3. Third period goals by Tice and Fontaine.

Our CSO Jon Pachter looks forward to presenting on how the RAF/MEK clamp avutometinib enhances antitumor efficacy of KRAS G12C and G12D inhibitors at the upcoming AACR Special Conference on Targeting RAS.

Happy Teal Tuesday from the Back To Back To Back Ice Hockey Champs!!👌🏻👌🏻

Introducing Let’s Talk About LGSOC, a new initiative to support broader awareness, education, and support for patients living with #LGSOC, a rare and often misunderstood form of ovarian cancer. Visit this website to learn more: letstalkaboutlgsoc.com

This #WomensHealthMonth, follow our journey to support patients, advocacy organizations, and researchers working to raise awareness and educate others about #LGSOC, a rare and often misunderstood form of ovarian cancer. Visit LetsTalkAboutLGSOC.com to learn more.

#ANNOUNCEMENT: We're proud to announce the appointment of Karin Tollefson, SVP & Head of Global Medical Affairs @SeagenGlobal, to our Board of Directors. Learn more here: bit.ly/4305NcN

“I firmly believe that by bridging innovative research with robust community engagement, we create an empowering environment where those impacted by #lowgradeserous #ovariancancer feel heard, understood & supported.” Hear more from $VSTM CEO Dan Paterson bit.ly/3u94UCA